Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Nov 15;98(10):2218–2227. doi: 10.1172/JCI119031

Osteopontin is produced by rat cardiac fibroblasts and mediates A(II)-induced DNA synthesis and collagen gel contraction.

N Ashizawa 1, K Graf 1, Y S Do 1, T Nunohiro 1, C M Giachelli 1, W P Meehan 1, T L Tuan 1, W A Hsueh 1
PMCID: PMC507670  PMID: 8941637

Abstract

Angiotensin II (AII) is a critical factor in cardiac remodeling which involves hypertrophy, fibroblast proliferation, and extracellular matrix production. However, little is known about the mechanism by which AII accelerates these responses. Osteopontin is an acidic phosphoprotein with RGD (arginine-glycine-aspartate) sequences that are involved in the vascular smooth muscle cell remodeling process. We identified the presence of osteopontin mRNA and protein in cultured rat cardiac fibroblasts and its prominent regulation by AII (10(-11) M). Osteopontin message levels were increased fourfold (P < 0.01) and protein fivefold (P < 0.05) at 24 h after addition of AII (10(-7) M). This response was inhibited by the AT1 receptor blocker, losartan. Osteopontin mRNA levels were increased in hypertrophied ventricles from animals with renovascular hypertension (1.6-fold, P < 0.05) and aortic banding (2.9-fold, P < 0.05). To examine the function of osteopontin, we determined its effects on (a) the ability of cardiac fibroblasts to contract three-dimensional collagen gels and (b) cardiac fibroblast growth. A monoclonal antibody against osteopontin partially blocked AII-induced three-dimensional collagen gel contraction by cardiac fibroblasts (64+/-4 vs. 86+/-5% in the presence of antibody, P < 0.05), while osteopontin itself promoted contraction of the gels by fibroblasts (71+/-5%, P < 0.05 compared with control). Either a monoclonal antibody against beta3 integrin which is a ligand for osteopontin or the RGD peptide blocked both AII and osteopontin-induced collagen gel contraction. Thus, the osteopontin RGD sequence binds to beta3 integrins on the fibroblast to promote fibroblast binding to collagen. All induced a threefold increase in DNA synthesis of cardiac fibroblasts, which was completely blocked by antibodies against osteopontin and beta3 integrin, or by RGD peptide, but not by controls. Thus, All-induced growth of cardiac fibroblasts also requires osteopontin engagement of the beta3 integrin. Taken together, these results provide the first evidence that osteopontin is a potentially important mediator of AII regulation of cardiac fibroblast behavior in the cardiac remodeling process.

Full Text

The Full Text of this article is available as a PDF (474.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baker K. M., Booz G. W., Dostal D. E. Cardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol. 1992;54:227–241. doi: 10.1146/annurev.ph.54.030192.001303. [DOI] [PubMed] [Google Scholar]
  2. Boluyt M. O., O'Neill L., Meredith A. L., Bing O. H., Brooks W. W., Conrad C. H., Crow M. T., Lakatta E. G. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix components. Circ Res. 1994 Jul;75(1):23–32. doi: 10.1161/01.res.75.1.23. [DOI] [PubMed] [Google Scholar]
  3. Brown L. F., Berse B., Van de Water L., Papadopoulos-Sergiou A., Perruzzi C. A., Manseau E. J., Dvorak H. F., Senger D. R. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell. 1992 Oct;3(10):1169–1180. doi: 10.1091/mbc.3.10.1169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buchanan T. A., Sipos G. F., Gadalah S., Yip K. P., Marsh D. J., Hsueh W., Bergman R. N. Glucose tolerance and insulin action in rats with renovascular hypertension. Hypertension. 1991 Sep;18(3):341–347. doi: 10.1161/01.hyp.18.3.341. [DOI] [PubMed] [Google Scholar]
  5. Burgess M. L., Carver W. E., Terracio L., Wilson S. P., Wilson M. A., Borg T. K. Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res. 1994 Feb;74(2):291–298. doi: 10.1161/01.res.74.2.291. [DOI] [PubMed] [Google Scholar]
  6. Butler W. T. The nature and significance of osteopontin. Connect Tissue Res. 1989;23(2-3):123–136. doi: 10.3109/03008208909002412. [DOI] [PubMed] [Google Scholar]
  7. Chen Y., Bal B. S., Gorski J. P. Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem. 1992 Dec 5;267(34):24871–24878. [PubMed] [Google Scholar]
  8. Cheresh D. A., Smith J. W., Cooper H. M., Quaranta V. A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell. 1989 Apr 7;57(1):59–69. doi: 10.1016/0092-8674(89)90172-4. [DOI] [PubMed] [Google Scholar]
  9. Choi E. T., Engel L., Callow A. D., Sun S., Trachtenberg J., Santoro S., Ryan U. S. Inhibition of neointimal hyperplasia by blocking alpha V beta 3 integrin with a small peptide antagonist GpenGRGDSPCA. J Vasc Surg. 1994 Jan;19(1):125–134. doi: 10.1016/s0741-5214(94)70127-x. [DOI] [PubMed] [Google Scholar]
  10. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  11. Dahlöf B., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens. 1992 Feb;5(2):95–110. doi: 10.1093/ajh/5.2.95. [DOI] [PubMed] [Google Scholar]
  12. Denhardt D. T., Guo X. Osteopontin: a protein with diverse functions. FASEB J. 1993 Dec;7(15):1475–1482. [PubMed] [Google Scholar]
  13. Everett A. D., Tufro-McReddie A., Fisher A., Gomez R. A. Angiotensin receptor regulates cardiac hypertrophy and transforming growth factor-beta 1 expression. Hypertension. 1994 May;23(5):587–592. doi: 10.1161/01.hyp.23.5.587. [DOI] [PubMed] [Google Scholar]
  14. Gardner H. A., Berse B., Senger D. R. Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene. 1994 Aug;9(8):2321–2326. [PubMed] [Google Scholar]
  15. Giachelli C. M., Bae N., Almeida M., Denhardt D. T., Alpers C. E., Schwartz S. M. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest. 1993 Oct;92(4):1686–1696. doi: 10.1172/JCI116755. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gillery P., Maquart F. X., Borel J. P. Fibronectin dependence of the contraction of collagen lattices by human skin fibroblasts. Exp Cell Res. 1986 Nov;167(1):29–37. doi: 10.1016/0014-4827(86)90201-6. [DOI] [PubMed] [Google Scholar]
  17. Guidry C., Grinnell F. Contraction of hydrated collagen gels by fibroblasts: evidence for two mechanisms by which collagen fibrils are stabilized. Coll Relat Res. 1987 Feb;6(6):515–529. doi: 10.1016/s0174-173x(87)80050-x. [DOI] [PubMed] [Google Scholar]
  18. Harpold M. M., Evans R. M., Salditt-Georgieff M., Darnell J. E. Production of mRNA in Chinese hamster cells: relationship of the rate of synthesis to the cytoplasmic concentration of nine specific mRNA sequences. Cell. 1979 Aug;17(4):1025–1035. doi: 10.1016/0092-8674(79)90341-6. [DOI] [PubMed] [Google Scholar]
  19. Harter L. V., Hruska K. A., Duncan R. L. Human osteoblast-like cells respond to mechanical strain with increased bone matrix protein production independent of hormonal regulation. Endocrinology. 1995 Feb;136(2):528–535. doi: 10.1210/endo.136.2.7530647. [DOI] [PubMed] [Google Scholar]
  20. Helfrich M. H., Nesbitt S. A., Horton M. A. Integrins on rat osteoclasts: characterization of two monoclonal antibodies (F4 and F11) to rat beta 3. J Bone Miner Res. 1992 Mar;7(3):345–351. doi: 10.1002/jbmr.5650070315. [DOI] [PubMed] [Google Scholar]
  21. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 1992 Apr 3;69(1):11–25. doi: 10.1016/0092-8674(92)90115-s. [DOI] [PubMed] [Google Scholar]
  22. Iwami K., Ashizawa N., Do Y. S., Graf K., Hsueh W. A. Comparison of ANG II with other growth factors on Egr-1 and matrix gene expression in cardiac fibroblasts. Am J Physiol. 1996 Jun;270(6 Pt 2):H2100–H2107. doi: 10.1152/ajpheart.1996.270.6.H2100. [DOI] [PubMed] [Google Scholar]
  23. Juliano R. L., Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 1993 Feb;120(3):577–585. doi: 10.1083/jcb.120.3.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Knowlton K. U., Michel M. C., Itani M., Shubeita H. E., Ishihara K., Brown J. H., Chien K. R. The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy. J Biol Chem. 1993 Jul 25;268(21):15374–15380. [PubMed] [Google Scholar]
  25. Liaw L., Almeida M., Hart C. E., Schwartz S. M., Giachelli C. M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ Res. 1994 Feb;74(2):214–224. doi: 10.1161/01.res.74.2.214. [DOI] [PubMed] [Google Scholar]
  26. Liaw L., Skinner M. P., Raines E. W., Ross R., Cheresh D. A., Schwartz S. M., Giachelli C. M. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest. 1995 Feb;95(2):713–724. doi: 10.1172/JCI117718. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Linz W., Schölkens B. A., Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens A. 1989;11(7):1325–1350. doi: 10.3109/10641968909038172. [DOI] [PubMed] [Google Scholar]
  28. Mamuya W. S., Brecher P. Fibronectin expression in the normal and hypertrophic rat heart. J Clin Invest. 1992 Feb;89(2):392–401. doi: 10.1172/JCI115598. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Matsubara H., Kanasaki M., Murasawa S., Tsukaguchi Y., Nio Y., Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest. 1994 Apr;93(4):1592–1601. doi: 10.1172/JCI117139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Morkin E., Ashford T. P. Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol. 1968 Dec;215(6):1409–1413. doi: 10.1152/ajplegacy.1968.215.6.1409. [DOI] [PubMed] [Google Scholar]
  31. Mukherjee B. B., Nemir M., Beninati S., Cordella-Miele E., Singh K., Chackalaparampil I., Shanmugam V., DeVouge M. W., Mukherjee A. B. Interaction of osteopontin with fibronectin and other extracellular matrix molecules. Ann N Y Acad Sci. 1995 Apr 21;760:201–212. doi: 10.1111/j.1749-6632.1995.tb44631.x. [DOI] [PubMed] [Google Scholar]
  32. Murry C. E., Giachelli C. M., Schwartz S. M., Vracko R. Macrophages express osteopontin during repair of myocardial necrosis. Am J Pathol. 1994 Dec;145(6):1450–1462. [PMC free article] [PubMed] [Google Scholar]
  33. Sadoshima J., Xu Y., Slayter H. S., Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993 Dec 3;75(5):977–984. doi: 10.1016/0092-8674(93)90541-w. [DOI] [PubMed] [Google Scholar]
  34. Schieffer B., Wirger A., Meybrunn M., Seitz S., Holtz J., Riede U. N., Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation. 1994 May;89(5):2273–2282. doi: 10.1161/01.cir.89.5.2273. [DOI] [PubMed] [Google Scholar]
  35. Singh K., Balligand J. L., Fischer T. A., Smith T. W., Kelly R. A. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells. Role in regulation of inducible nitric oxide synthase. J Biol Chem. 1995 Nov 24;270(47):28471–28478. doi: 10.1074/jbc.270.47.28471. [DOI] [PubMed] [Google Scholar]
  36. Sollott S. J., Cheng L., Pauly R. R., Jenkins G. M., Monticone R. E., Kuzuya M., Froehlich J. P., Crow M. T., Lakatta E. G., Rowinsky E. K. Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat. J Clin Invest. 1995 Apr;95(4):1869–1876. doi: 10.1172/JCI117867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Villarreal F. J., Kim N. N., Ungab G. D., Printz M. P., Dillmann W. H. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation. 1993 Dec;88(6):2849–2861. doi: 10.1161/01.cir.88.6.2849. [DOI] [PubMed] [Google Scholar]
  38. Weber K. T., Janicki J. S., Shroff S. G., Pick R., Chen R. M., Bashey R. I. Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium. Circ Res. 1988 Apr;62(4):757–765. doi: 10.1161/01.res.62.4.757. [DOI] [PubMed] [Google Scholar]
  39. Williams E. B., Halpert I., Wickline S., Davison G., Parks W. C., Rottman J. N. Osteopontin expression is increased in the heritable cardiomyopathy of Syrian hamsters. Circulation. 1995 Aug 15;92(4):705–709. doi: 10.1161/01.cir.92.4.705. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES